Literature DB >> 1122779

Iatrogenic arteriovenous fistula: a complication of percutaneous subclavian vein puncture.

K Farhat, K Nakhjavan, C Cope, S Yazdanfar, J Fernandez, A Gooch, H Goldberg.   

Abstract

A case of iatrogenic subclavian arteriovenous fistula is reported. An intracath had been inserted percutaneously into the left subclavian vein to monitor the central venous pressure during aortic valve surgery. On the second postoperative day a thrill and continuous murmur were detected at the left subclavian region. Left subclavian arteriogram and catheterization studies confirmed the diagnosis of subclavian arteriovenous fistula. The lesion was treated surgically with satisfactory results.

Entities:  

Mesh:

Year:  1975        PMID: 1122779     DOI: 10.1378/chest.67.4.480

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  SUCCESSFUL SURGICAL MANAGEMENT OF CONGENITAL ARTERIOVENOUS FISTULA OF THE SUBCLAVIAN ARTERY: CASE REPORT.

Authors:  J Michael Duncan; Denton A. Cooley; Thomas A. Vargo; Howard P. Gutgesell
Journal:  Cardiovasc Dis       Date:  1978-06

2.  Delayed recognition of vascular complications caused by central venous catheters.

Authors:  C B Kapadia; S O Heard; N S Yeston
Journal:  J Clin Monit       Date:  1988-10

3.  Use of subclavian vein for permanent cardiac pacing.

Authors:  G P McNeill; N C Taylor
Journal:  Br Heart J       Date:  1978-02

4.  Permanent cardiac pacing using anterior pectoral veins.

Authors:  A G Arnold
Journal:  Br Heart J       Date:  1980-03

5.  Arteriovenous fistulas following central venous catheterization.

Authors:  J F Hansbrough; J A Narrod; R Rutherford
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

6.  Transvenous Fogarty balloon catheter occlusion of an iatrogenic innominate artery to innominate vein fistula.

Authors:  R D Patterson; T A Tomsick; J H Wilson; R T Frey; A Deak; T Schreiber
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.